AMS企画株式会社
Tokyo, JP · Founded 2019 · 2 known investors
Find your way into AMS企画株式会社
Sign up to see every warm intro you have to AMS企画株式会社
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AMS企画株式会社 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AMS develops next-generation nuclear medicine technologies for Japan's market, including PET diagnostics and radiotherapeutics for precision oncology, alongside a proprietary bedside filtration system for safe radioactive waste management in hospitals.
Founders & leadership
YS
Yuichiro SugawaraRepresentative Director, President and CEO
Investors · 2
Frequently asked questions
- What does AMS企画株式会社 do?
- AMS develops next-generation nuclear medicine technologies for Japan's market, including PET diagnostics and radiotherapeutics for precision oncology, alongside a proprietary bedside filtration system for safe radioactive waste management in hospitals.
- Who are AMS企画株式会社's investors?
- AMS企画株式会社's investors include MIRAI SOUZOU, Vision Incubate.
- Where is AMS企画株式会社 headquartered?
- AMS企画株式会社 is headquartered in Tokyo, JP.